This clinical-stage biotech focused on cystic fibrosis therapies reported a notable insider sale amid a year of sharp ...
And as we invite back our nine intrepid fund managers for their best picks for 2026 and reflection on their past ...
Michael Cloonan, President and CEO of Sionna Therapeutics, Inc. (NASDAQ:SION), sold a total of 25,200 shares of common stock on October 15 and 16, 2025. The sales were executed at prices ranging from ...
According to TipRanks.com, Baral is a top 100 analyst with an average return of 43.2% and a 56.1% success rate. Baral covers the Healthcare sector, focusing on stocks such as Sagimet Biosciences, Inc.
Wayfair (NASDAQ:W) Chief Executive Officer Niraj Shah sold 151,024 shares of Class A Common Stock on December 23 and 26, 2025, generating approximately $15.1 million. The transactions occurred at ...